Arthrosi Therapeutics has raised $153 million to bankroll its bid to clout gout. The series E financing gives the biotech the financial firepower to deliver data from two phase 3 trials next year. San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback